The field of congenital interventional cardiology has experienced tremendous growth in
recent years. Beginning with the development of early devices for transcatheter closure of …

Right ventricular function strongly predicts cardiac death and adverse cardiac events in
patients with cardiac diseases. However, the accurate right ventricular assessment by two …

Background and aim: The GORE® CARDIOFORM (GCO) septal occluder is an atrial septal
defect/patent foramen ovale closure device with theoretical advantages over other …

Introduction: Technologically, advances in both transcatheter and surgical techniques have
been continuing in the past 20 years, but an updated comprehensive comparison in device …

Transcatheter device intervention is now offered as first line therapy for many congenital
heart defects (CHD) which were traditionally treated with cardiac surgery. While off-label use …

Background This perspective, observational study evaluated safety and efficacy of the
GORE® Cardioform ASD Occluder (WL Gore & Associates, Flagstaff, AZ), compliant and …

Novel cardiac devices, including the MitraClip system, occluder devices, leadless
pacemakers, and subcutaneous implantable cardioverter defibrillators (S-ICD), are mostly …

Background. Nowadays, transcatheter device closure of an atrial septal defect (ASD) is a
standard approach in children. Potential early and long‐term side effects or complications …

A patent foramen ovale (PFO) is a frequent incidental finding during echocardiography in
otherwise healthy children. In most healthy children with a diagnosis of isolated incidental …

A variety of both acquired and congenital conditions can significantly affect the right
ventricle, with a variety of potential origins that can have substantial clinical ramifications …